<?xml version="1.0" encoding="UTF-8"?>
<p>Starting from DGLA, both anti-inflammatory PG1 and pro-inflammatory PG2, through the conversion into arachidonic acid, can be produced (
 <xref ref-type="fig" rid="vaccines-08-00468-f007">Figure 7</xref>). 
</p>
